Alfaifi Hassan, Abdelwahab Siddig Ibrahim, Mohan Syam, Elhassan Taha Manal Mohamed, Syame Sohier M, Shaala Lamiaa A, Alsanosy Rashad
Department of Pharmacology, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.
Substance Abuse Research Centre, Jazan University, 11420, Jazan, Saudi Arabia.
Pharmacogn Mag. 2017 Jul;13(Suppl 2):S354-S358. doi: 10.4103/pm.pm_442_16. Epub 2017 Jul 11.
Forsk. (Khat) is traditionally used for treating various disorders. Nevertheless there are no reports of any scientific assessment of its psychopharmacological properties.
Therefore, the current study was designed to evaluate the antidepressant-like activity of Khat ethanolic extract using established animal models of depression and stress.
Ninety healthy male albino mice were used in this study. Forced swim, tail suspension and head poking tests were utilized to evaluate the antidepressant-like activity of the ethanolic extract of Khat (100, 200 and 400 mg/kg, i.p.) and escitalopram (standard drug) which were administered 30 min prior to the tests. Phytochemical analysis of the standardized extract was conducted using liquid chromatography-mass spectroscopy (LC-MS).
A significant decrease in the head-dipping behavior was noticed after administration of 100, 200 and 400 mg/kg of Khat extract. Moreover, the extract significantly decreased the immobility time in tail suspension and forced swim tests. The presence of cathinone and cathine were detected in the extract using LC-MS.
The current results suggest that the extract of Khat leaves has acute antidepressant properties and may have sedative effects.
Antidepressant-like activity of Khat established The extract decreased the immobility time in tail suspension and forced swim testsLiquid chromatography-mass spectroscopy data revealed the presence of cathinone and cathine in Khat extract. LC-MS: Liquid chromatography-mass spectroscopy; NIST: National institute of standard technology; SSRI: Serotonin reuptake inhibitors; FST: Forced swim test; TST: Tail suspension test.
巧茶传统上用于治疗各种疾病。然而,尚无关于其精神药理学特性的任何科学评估报告。
因此,本研究旨在使用已建立的抑郁和应激动物模型评估巧茶乙醇提取物的抗抑郁样活性。
本研究使用了90只健康的雄性白化小鼠。强迫游泳、悬尾和头部探测试验用于评估巧茶乙醇提取物(100、200和400mg/kg,腹腔注射)和艾司西酞普兰(标准药物)的抗抑郁样活性,在试验前30分钟给药。使用液相色谱 - 质谱联用仪(LC-MS)对标准化提取物进行植物化学分析。
给予100、200和400mg/kg巧茶提取物后,头部浸入行为显著减少。此外,该提取物在悬尾和强迫游泳试验中显著减少了不动时间。使用LC-MS在提取物中检测到了去甲伪麻黄碱和卡西酮的存在。
目前的结果表明,巧茶叶提取物具有急性抗抑郁特性,可能具有镇静作用。
巧茶的抗抑郁样活性得以确立 提取物在悬尾和强迫游泳试验中减少了不动时间 液相色谱 - 质谱联用仪数据显示巧茶提取物中存在去甲伪麻黄碱和卡西酮。LC-MS:液相色谱 - 质谱联用仪;NIST:美国国家标准技术研究所;SSRI:血清素再摄取抑制剂;FST:强迫游泳试验;TST:悬尾试验